France, Health
Do microbes control our mood?
Do microbes control our mood? If aliens were to examine a human, they would think we were just slavish organisms designed to feed microbes and carry them around. Our bodies contain ten times more bacteria than cells , and there are an estimated 3.
Is it a real food allergy?
Is it a real food allergy? Whenever you eat strawberries, does your throat start to swell and itch? Do you also get a burning or prickling sensation in your lips, gums, tongue or inside your cheeks? Or perhaps drinking milk ...
New treatment against transplantation complications tested
New treatment against transplantation complications tested It is not uncommon for kidney transplants to fail. Once transplanted, the kidney must connect back with the blood supply to start working properly and be truly accepted by the body. Delays can cause complications.
Twins help progress and diagnosis of rare Myasthenia
Twins help progress and diagnosis of rare Myasthenia Fourteen pairs of identical twins joined the EU funded medical project “ Fight-MG ”, to fight Myasthenia Gravis . This rare autoimmune disease leads to abnormal fatigability of various skeletal muscles.
Sonia Aknin-Berrih: How rare models suggest new treatment strategies
Sonia Aknin-Berrih: How rare models suggest new treatment strategies Myasthenia Gravis (MG) is a rare auto-immune disease—whereby patients’ immune systems attack their own bodies— arising from a breakdown in communications between the nervous and muscular systems.
Network of experts join forces to fight rare disease
Network of experts join forces to fight rare disease Collaboration between research groups is key in tackling rare diseases such as auto-immune disease Myasthenia Gravis (MG). Indeed, the rarity of the disease means that it can be difficult to collect enough samples of blood and tissues to perform quality research.
Picking the right virus candidate for gene therapy
Picking the right virus candidate for gene therapy Viruses often get bad press. Likened to Trojan horses they are often associated with disease. But, i t is precisely because of their infectious nature that they can potentially be used as gene vectors - which are vehicles loaded with good copies of malfunctioning genes - and delivered to cells.
Eric Kremer – Delivering therapy beyond the blood-brain barrier
Eric Kremer – Delivering therapy beyond the blood-brain barrier Brain diseases are particularly challenging to treat. Every substance that has to be delivered to the brain needs to overcome several obstacles, such as the blood-brain barrier—a system that prevents potentially dangerous substances, but also many drugs, to enter this organ—,to get to its target.
Greater granularity on anthropogenic emission
Greater granularity on anthropogenic emission Anthropogenic emissions have, until now, been collected, but not harmonised . These consist, for example, of data of nitrogen oxides (NOx) emissions, smog, methane, CO 2 and even pollen and dust produced, among others by heavy industry and power plants.
Fighting resistance to antimalarial drug
Fighting resistance to antimalarial drug When it comes to the emergence of antimalarial drug resistance, it’s not a question of ‘if’ but ‘when’.
Gordon Langsley – Focus on biological signalling to defeat malaria
Gordon Langsley – Focus on biological signalling to defeat malaria Millions of people die each year of malaria – a disease transmitted by the Anopheles mosquito. There are major barriers in vaccine development as well as increased resistance to currently available therapies.
Peering down protein-DNA interactions to better understand how genes work
Peering down protein-DNA interactions to better understand how genes work Almost every one of our cells has an entire copy of our genome. But only differing subsets of genes are active and expressed in any given cell. Epigenetics is the study of how the activity of our genes is controlled and regulated .
Common links between neurodegenerative diseases identified
Common links between neurodegenerative diseases identified Diseases of the central nervous system are a big burden to society . According to estimates, they cost €800 billion per year in Europe. And for most of them, there is no definitive cure.
The fight against hepatitis C in Egypt
The fight against hepatitis C in Egypt There is a hepatitis C epidemic in Egypt. Ironically, this is in large part due to a public health campaign in the 1960s and 1970s, during which injection needles were being re-used.
When air quality governs traffic management
When air quality governs traffic management Poor air quality costs Europe more than €700 million per year, in health expenditures and loss of economic performance, according to official EU sources.
Camille Locht – an innovative solution to infant whooping cough
Camille Locht – an innovative solution to infant whooping cough Scientists involved in the EU-funded project ChildInnovac are about to publish in the online journal Plos One the results of their first clinical trial of a new nasal vaccine.
Nasal vaccine: towards an alternative to injection for infants
Nasal vaccine: towards an alternative to injection for infants Whooping cough and bronchiolitis are respiratory infections frequently affecting young children. In particular, infants under three months are very sensitive to these illnesses, which can lead to death in the most severe cases .
New Vaccine to Protect Babies from Whooping Cough
New Vaccine to Protect Babies from Whooping Cough In Europe, whooping cough ( Pertussis ) is in the increase, with more than 20.000 cases reported annually . Often infants fall victim to the disease, where it can be life-threatening.
Too tasty for your own good
Too tasty for your own good Fat, sugar and salt - these ingredients are often used by the food industry to enrich their products and provide us with the perfect sensual experience. Now, scientists in France are trying to reverse this trend.
Nicolas Mouz - progressing towards an efficient HIV vaccine
Nicolas Mouz - progressing towards an efficient HIV vaccine European researchers have designed two new vaccine candidates to fight the HIV virus. These have been developed within the EU-funded project EURONEUT 41 .
Page: 1 2